La cadena de opciones muestra datos clave de las opciones de acciones de Moleculin Biotech a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Moleculin Biotech..

Moleculin Biotech (NASDAQ:MBRX) Bolsa, Cadena de Opciones

Moleculin Biotech

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

APPS

AVGR

BBAI

COHR

DGLY

FORM

MBRX

MTRX

PTIX

RANI

RXRX

SBET

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SLXN

SWKS

Coherent sorprende con sus resultados trimestrales y dispara sus acciones un 15,5%. ¿Qué otras empresas se mueven en el premercado de EE.UU.?

Acciones de Coherent (COHR) se disparan un 15%; 20 acciones que se mueven en el premercado de EE.UU.

Moleculin Biotech Inc

<p>In the preceding three months, 4 analysts have released ratings for FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $42.5, a high estimate of $51.00, and a low estimate of $34.00. Experiencing a 17.48% decline, the current average is now lower than the previous average price target of $51.50. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872069_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>The perception of FormFactor by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Chin</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$42.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Vedvati Shrotre</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$43.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Craig Ellis</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$34.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Atif Malik</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$51.00</td>
<td>$44.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to FormFactor. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of FormFactor compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts predict movements in price targets, offering estimates for FormFactor's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of FormFactor's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/FORM/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on FormFactor analyst ratings.</strong></a></p>
<h2>Delving into FormFactor's Background</h2>
<p>FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.</p>
<h3>Unraveling the Financial Story of FormFactor</h3>
<p><strong>Market Capitalization Analysis:</strong> Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> FormFactor displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately <strong>21.18%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.</p>
<p><strong>Net Margin:</strong> FormFactor's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>9.01%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> FormFactor's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>1.97%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> FormFactor's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.62%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.04</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

A Glimpse Into The Expert Outlook On FormFactor Through 4 Analysts

<p>Across the recent three months, 8 analysts have shared their insights on Essex Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESS#NYSE">ESS</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $307.62, along with a high estimate of $316.00 and a low estimate of $300.00. Highlighting a 1.45% decrease, the current average has fallen from the previous average price target of $312.14. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872059_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>A clear picture of Essex Property Trust's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brad Heffern</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$315.00</td>
<td>$302.00</td>
</tr>
<tr>
<td>James Feldman</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$305.00</td>
<td>$314.00</td>
</tr>
<tr>
<td>Richard Hightower</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$302.00</td>
<td>$316.00</td>
</tr>
<tr>
<td>Omotayo Okusanya</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$310.00</td>
<td>$308.00</td>
</tr>
<tr>
<td>John Kim</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$310.00</td>
<td>$323.00</td>
</tr>
<tr>
<td>Vikram Malhorta</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$300.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>Anthony Paolone</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$303.00</td>
<td>$297.00</td>
</tr>
<tr>
<td>Anthony Powell</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$316.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Essex Property Trust. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Essex Property Trust compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>For valuable insights into Essex Property Trust's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/ESS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Essex Property Trust analyst ratings.</strong></a></p>
<h2>Delving into Essex Property Trust's Background</h2>
<p>Essex Property Trust owns a portfolio of 254 apartment communities with over 62,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.</p>
<h3>Breaking Down Essex Property Trust's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Essex Property Trust's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>7.52%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Essex Property Trust's net margin excels beyond industry benchmarks, reaching <strong>26.28%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>2.17%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Essex Property Trust's ROA excels beyond industry benchmarks, reaching <strong>0.94%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Essex Property Trust's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>1.18</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Demystifying Essex Property Trust: Insights From 8 Analyst Reviews

<p>Throughout the last three months, 7 analysts have evaluated MPLX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLX#NYSE">MPLX</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated MPLX and provided 12-month price targets. The average target is $55.29, accompanied by a high estimate of $60.00 and a low estimate of $52.00. This current average reflects an increase of 7.51% from the previous average price target of $51.43. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872052_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of MPLX among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Justin Jenkins</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$60.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Michael Blum</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$59.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Theresa Chen</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$52.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Michael Blum</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$54.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$55.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Elvira Scotto</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$52.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Brian Reynolds</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$55.00</td>
<td>$51.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MPLX. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of MPLX compared to the broader market.</li>
<li><strong>Price Targets:</strong> Delving into movements, analysts provide estimates for the future value of MPLX's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of MPLX's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/MPLX/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on MPLX analyst ratings.</strong></a></p>
<h2>Discovering MPLX: A Closer Look</h2>
<p>MPLX is a partnership that owns both pipelines and gathering and processing assets with extensive holdings in the Appalachian region. The asset base is made up of pipeline assets dropped down from Marathon Petroleum, its sponsor, and gathering and processing assets from MarkWest, which it acquired in 2015. MPLX also acquired Andeavor Logistics in 2019.</p>
<h3>Financial Insights: MPLX</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> MPLX displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately <strong>2.28%</strong>. This indicates a notable increase in the company's top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> MPLX's net margin excels beyond industry benchmarks, reaching <strong>37.14%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> MPLX's ROE excels beyond industry benchmarks, reaching <strong>7.52%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> MPLX's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>2.68%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>1.66</strong>, MPLX adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Analyst Ratings: Simplified</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


MPLX

MPLX Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

<p>CSG Systems Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGS#NASDAQ">CSGS</a>) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for CSG Systems Intl, revealing an average target of $70.4, a high estimate of $80.00, and a low estimate of $65.00. Witnessing a positive shift, the current average has risen by 13.18% from the previous average price target of $62.20.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872045_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>In examining recent analyst actions, we gain insights into how financial experts perceive CSG Systems Intl. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Shlomo Rosenbaum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$66.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$69.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Michael Berg</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$65.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Brett Knoblauch</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Overweight</td>
<td>$72.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Nehal Chokshi</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$80.00</td>
<td>$78.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CSG Systems Intl. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of CSG Systems Intl compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of CSG Systems Intl's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>To gain a panoramic view of CSG Systems Intl's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CSGS/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on CSG Systems Intl analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Get to Know CSG Systems Intl Better</h2>
<p>CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from Americas (principally the U.S.).</p>
<h3>CSG Systems Intl's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, CSG Systems Intl showcased positive performance, achieving a revenue growth rate of <strong>2.88%</strong> as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> CSG Systems Intl's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>6.47%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> CSG Systems Intl's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>6.8%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> CSG Systems Intl's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>1.39%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> CSG Systems Intl's debt-to-equity ratio surpasses industry norms, standing at <strong>2.0</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CSGS

5 Analysts Have This To Say About CSG Systems Intl

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>CF Industries Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CF#NYSE">CF</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CF, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 9 uncommon options trades for CF Industries Holdings.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 44% bullish and 33%, bearish.</p>
<p>Out of all of the special options we uncovered, 5 are puts, for a total amount of $405,360, and 4 are calls, for a total amount of $170,618.</p>
<h3>Projected Price Targets</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $85.0 and $97.5 for CF Industries Holdings, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for CF Industries Holdings's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CF Industries Holdings's whale trades within a strike price range from $85.0 to $97.5 in the last 30 days. </p>
<h3>CF Industries Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872042_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CF</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$12.3</td>
<td>$12.2</td>
<td>$12.3</td>
<td>$97.50</td>
<td>$246.0K</td>
<td align="right">567</td>
<td>200</td>
</tr>
<tr>
<td>CF</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/07/25</td>
<td>$1.0</td>
<td>$0.4</td>
<td>$0.7</td>
<td>$86.00</td>
<td>$62.9K</td>
<td align="right">15</td>
<td>1.0K</td>
</tr>
<tr>
<td>CF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$5.5</td>
<td>$5.3</td>
<td>$5.3</td>
<td>$87.50</td>
<td>$46.6K</td>
<td align="right">99</td>
<td>88</td>
</tr>
<tr>
<td>CF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$7.2</td>
<td>$6.9</td>
<td>$7.2</td>
<td>$85.00</td>
<td>$43.1K</td>
<td align="right">826</td>
<td>66</td>
</tr>
<tr>
<td>CF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$7.0</td>
<td>$6.7</td>
<td>$6.85</td>
<td>$85.00</td>
<td>$41.8K</td>
<td align="right">826</td>
<td>206</td>
</tr>
</tbody>
</table>
</p>
<h3>About CF Industries Holdings</h3>
<p>CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally. The company is also investing in carbon-free blue and green ammonia, which can be used an alternative fuel to hydrogen or as a means to transport hydrogen.</p>
<h3>Present Market Standing of CF Industries Holdings</h3>
<ul>
<li>With a trading volume of 3,290,990, the price of CF is down by -7.16%, reaching $83.26.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 13 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for CF Industries Holdings</h3>
<p>Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $99.2.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from UBS has decided to maintain their Neutral rating on CF Industries Holdings, which currently sits at a price target of $92.<br />
&#x2A; An analyst from Oppenheimer persists with their Outperform rating on CF Industries Holdings, maintaining a target price of $111.<br />
&#x2A; Reflecting concerns, an analyst from Scotiabank lowers its rating to Sector Underperform with a new price target of $88.<br />
&#x2A; An analyst from RBC Capital has revised its rating downward to Sector Perform, adjusting the price target to $100.<br />
&#x2A; In a positive move, an analyst from Piper Sandler has upgraded their rating to Overweight and adjusted the price target to $105. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for CF Industries Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

CF Industries Holdings's Options: A Look at What the Big Money is Thinking

<p>Deep-pocketed investors have adopted a bullish approach towards Axon Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AXON usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Axon Enterprise. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 50% leaning bullish and 40% bearish. Among these notable options, 4 are puts, totaling $180,000, and 6 are calls, amounting to $235,590.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $440.0 to $750.0 for Axon Enterprise over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Axon Enterprise's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Axon Enterprise's significant trades, within a strike price range of $440.0 to $750.0, over the past month.</p>
<h3>Axon Enterprise Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872037_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AXON</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$19.4</td>
<td>$18.7</td>
<td>$19.4</td>
<td>$590.00</td>
<td>$96.9K</td>
<td align="right">77</td>
<td align="right">1</td>
</tr>
<tr>
<td>AXON</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$266.0</td>
<td>$262.0</td>
<td>$263.0</td>
<td>$440.00</td>
<td>$78.9K</td>
<td align="right">55</td>
<td align="right">3</td>
</tr>
<tr>
<td>AXON</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$38.0</td>
<td>$37.5</td>
<td>$37.5</td>
<td>$700.00</td>
<td>$37.5K</td>
<td align="right">242</td>
<td align="right">16</td>
</tr>
<tr>
<td>AXON</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$119.9</td>
<td>$119.3</td>
<td>$119.3</td>
<td>$600.00</td>
<td>$35.7K</td>
<td align="right">166</td>
<td align="right">3</td>
</tr>
<tr>
<td>AXON</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$62.0</td>
<td>$58.8</td>
<td>$62.0</td>
<td>$610.00</td>
<td>$31.0K</td>
<td align="right">141</td>
<td align="right">7</td>
</tr>
</tbody>
</table>
</p>
<h3>About Axon Enterprise</h3>
<p>Axon Enterprise Inc develops, manufactures, and sells conducted energy devices and cloud-based digital evidence management software designed for use by law enforcement, corrections, military forces, private security personnel, and private individuals for personal defense. The company operates in two segments: Taser and software &amp; sensors. Taser develops and sells CEDs used for protecting users and virtual reality training. Software and sensors manufacture fully integrated hardware and cloud-based software solutions such as body cameras, automated license plate reading, and digital evidence management systems. Axon delivers its products worldwide and derives the majority of its revenue from the software &amp; sensors segment and geographically from the United States.</p>
<p>In light of the recent options history for Axon Enterprise, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Axon Enterprise Standing Right Now?</h3>
<ul>
<li>With a volume of 244,885, the price of AXON is down -2.25% at $665.2. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 19 days.</li>
</ul>
<h3>Expert Opinions on Axon Enterprise</h3>
<p>3 market experts have recently issued ratings for this stock, with a consensus target price of $708.3333333333334.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from TD Cowen has revised its rating downward to Buy, adjusting the price target to $700.<br />
&#x2A; Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for Axon Enterprise, targeting a price of $700.<br />
&#x2A; An analyst from JMP Securities has decided to maintain their Market Outperform rating on Axon Enterprise, which currently sits at a price target of $725. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Axon Enterprise options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


AXON

Axon Enterprise Unusual Options Activity

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Carpenter Tech</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with CRS, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 8 options trades for Carpenter Tech.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 50% bullish and 12%, bearish.</p>
<p>Out of all of the options we uncovered, 7 are puts, for a total amount of $394,310, and there was 1 call, for a total amount of $26,850.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $200.0 for Carpenter Tech, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Carpenter Tech's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Carpenter Tech's whale trades within a strike price range from $100.0 to $200.0 in the last 30 days. </p>
<h3>Carpenter Tech Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872031_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CRS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$26.9</td>
<td>$26.2</td>
<td>$26.9</td>
<td>$200.00</td>
<td>$107.3K</td>
<td align="right">0</td>
<td align="right">158</td>
</tr>
<tr>
<td>CRS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$12.2</td>
<td>$11.0</td>
<td>$11.78</td>
<td>$200.00</td>
<td>$74.2K</td>
<td align="right">249</td>
<td align="right">107</td>
</tr>
<tr>
<td>CRS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$27.7</td>
<td>$27.0</td>
<td>$27.0</td>
<td>$200.00</td>
<td>$51.3K</td>
<td align="right">0</td>
<td align="right">32</td>
</tr>
<tr>
<td>CRS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$28.9</td>
<td>$25.7</td>
<td>$27.2</td>
<td>$200.00</td>
<td>$48.9K</td>
<td align="right">0</td>
<td align="right">78</td>
</tr>
<tr>
<td>CRS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$28.8</td>
<td>$25.8</td>
<td>$26.7</td>
<td>$200.00</td>
<td>$48.0K</td>
<td align="right">0</td>
<td align="right">96</td>
</tr>
</tbody>
</table>
</p>
<h3>About Carpenter Tech</h3>
<p>Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.</p>
<p>After a thorough review of the options trading surrounding Carpenter Tech, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Carpenter Tech</h3>
<ul>
<li>Trading volume stands at 279,448, with CRS's price up by 2.15%, positioned at $196.85.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 83 days.</li>
</ul>
<h3>What Analysts Are Saying About Carpenter Tech</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $235.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from JP Morgan keeps a Overweight rating on Carpenter Tech with a target price of $235. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Carpenter Tech with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Looking At Carpenter Tech's Recent Unusual Options Activity

<p>Enterprise Prods Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for Enterprise Prods Partners, revealing an average target of $36.25, a high estimate of $40.00, and a low estimate of $33.00. A decline of 0.68% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872029_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Enterprise Prods Partners by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Spiro Dounis</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Holly Stewart</td>
<td>Scotiabank</td>
<td>Announces</td>
<td>Sector Perform</td>
<td>$33.00</td>
<td>-</td>
</tr>
<tr>
<td>Neal Dingmann</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Michael Blum</td>
<td>Wells Fargo</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$35.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Enterprise Prods Partners. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Enterprise Prods Partners compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of Enterprise Prods Partners's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Enterprise Prods Partners's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/EPD/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Enterprise Prods Partners analyst ratings.</strong></a></p>
<h2>Delving into Enterprise Prods Partners's Background</h2>
<p>Enterprise Products Partners is a master limited partnership that transports and processes natural gas, natural gas liquids, crude oil, refined products, and petrochemicals. It is one of the largest midstream companies, with operations servicing most producing regions in the Lower 48 states. Enterprise is particularly dominant in the NGL market and is one of the few MLPs that provide midstream services across the full hydrocarbon value chain.</p>
<h3>Understanding the Numbers: Enterprise Prods Partners's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Enterprise Prods Partners showcased positive performance, achieving a revenue growth rate of <strong>14.81%</strong> as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Energy sector.</p>
<p><strong>Net Margin:</strong> Enterprise Prods Partners's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>10.29%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Enterprise Prods Partners's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>5.03%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Enterprise Prods Partners's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>1.91%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>1.13</strong>.</p>
<h2>Analyst Ratings: What Are They?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Enterprise Prods Partners Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

<p>Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) has outperformed the market over the past 15 years by 1.33% on an annualized basis producing an average annual return of 13.48%. Currently, Johnson Controls Intl has a market capitalization of $57.72 billion. </p>
<p><strong>Buying $1000 In JCI:</strong> If an investor had bought $1000 of JCI stock 15 years ago, it would be worth <strong>$6,756.05</strong> today based on a price of $87.43 for JCI at the time of writing.</p>
<h3>Johnson Controls Intl's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872021_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$1000 Invested In Johnson Controls Intl 15 Years Ago Would Be Worth This Much Today

<p>During the last three months, 10 analysts shared their evaluations of Corpay (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $407.7, a high estimate of $445.00, and a low estimate of $350.00. This upward trend is evident, with the current average reflecting a 5.95% increase from the previous average price target of $384.80.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1738872015_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>A comprehensive examination of how financial experts perceive Corpay is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>John Davis</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$417.00</td>
<td>$434.00</td>
</tr>
<tr>
<td>Daniel Perlin</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$400.00</td>
<td>$354.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$445.00</td>
<td>$415.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$380.00</td>
<td>$350.00</td>
</tr>
<tr>
<td>Andrew Bauch</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$375.00</td>
<td>$340.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$415.00</td>
<td>$425.00</td>
</tr>
<tr>
<td>Rufus Hone</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$440.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$425.00</td>
<td>$400.00</td>
</tr>
<tr>
<td>Peter Christiansen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$430.00</td>
<td>$405.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$350.00</td>
<td>$325.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Corpay. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Corpay compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Corpay's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Corpay's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CPAY/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Corpay analyst ratings.</strong></a></p>
<h2>All You Need to Know About Corpay</h2>
<p>Corpay Inc is a global S&amp;P500 corporate payments company that helps businesses and consumers pay expenses in a simple, controlled manner. Its suite of modern payment solutions helps its customers better manage vehicle-related expenses (such as fueling and parking), travel expenses (e.g. hotel bookings), and payables (e.g. paying vendors). This results in its customers saving time and ultimately spending less.</p>
<h3>Corpay: A Financial Overview</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Corpay's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of <strong>6.01%</strong>. This signifies a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> Corpay's net margin excels beyond industry benchmarks, reaching <strong>26.86%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> Corpay's ROE excels beyond industry benchmarks, reaching <strong>9.47%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Corpay's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.63%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>2.51</strong>, Corpay faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CPAY

Demystifying Corpay: Insights From 10 Analyst Reviews

Macro Economic Events

Market Summary

Economics

General

RBLX

Benzinga Market Summary: Oil Falls As Trump Reaffirms Goal To Bring Down Prices, Roblox Falls On Q4 Results, S&P Falls

Fed's Waller Says Don't See a Case For A Retail CBDC In The US

WIIM

Molina Healthcare shares are trading lower after the company reported worse-than-expected FY24 adjusted EPS results.

XPO shares are trading higher following a Q4 earnings beat.

CGBS

CTRA

FANG

PTLE

TRGP

Shares of oil and gas companies are trading lower after President Trump reiterated a pledge to increase oil production.

<p>The Trump administration's buyout plan for federal employees is facing a legal roadblock after a federal judge temporarily halted the initiative just hours before <a href="https://www.benzinga.com/topic/donald-trump">the acceptance deadline Thursday. </a></p>
<p>The nationwide pause disrupts a controversial effort that could reshape the federal workforce by encouraging mass resignations, a move that critics argue is designed to clear out career officials, CNBC <a href="https://www.cnbc.com/2025/02/06/trump-federal-employee-buyout-court-challenge-.html">reports</a>.</p>
<p><strong>What Happened:</strong> A federal court in Boston intervened on Thursday to halt the administration's offer, which had already been accepted by more than 60,000 federal employees, or roughly 3% of the workforce. Judge <strong>George O'Toole Jr. </strong>ordered agencies to notify workers the program has been paused until at least Monday, when a hearing will determine the legal standing of the buyout plan.</p>
<p>The lawsuit, filed by unions representing federal workers, challenges the legality of the administration's so-called &#8220;Fork Directive," questioning its financial viability and legal basis.</p>
<p>The memo presented employees with a choice: resign now and continue receiving pay and benefits until September, or risk future layoffs. The administration insisted the deadline would not be extended beyond 11:59 p.m. ET Thursday, according to CNBC.</p>
<p>The American Federation of Government Employees has been vocal in its opposition, arguing the initiative pressures workers into resigning under uncertain conditions.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/02/43537016/donald-trump-once-said-bitcoin-was-based-on-thin-air-now-his-media-company-is-launching-btc-etf">Donald Trump Once Said Bitcoin &#8216;Was Based On Thin Air,&#8217; Now His Media Company Is Launching BTC ETF</a></strong></p>
<p><strong>Why It Matters:</strong> With over 3 million employees, the federal government is the largest employer in the U.S., surpassing corporations like <strong>Walmart</strong> and <strong>Amazon</strong> in workforce size. A large-scale departure could lead to significant disruptions in government operations, delaying services and impacting economic stability.</p>
<p>The Pew Research Center said even a fraction of federal employees opting into the buyout could cause widespread <a href="https://www.benzinga.com/news/25/01/43314808/trump-memo-heard-around-the-world-how-us-economy-could-adjust-to-buyouts-for-federal-workers">effects on public administration.</a></p>
<p>Critics argue the directive is politically motivated, aiming to replace career employees with administration loyalists. <strong>Everett Kelley</strong>, president of the American Federation of Government Employees, described the initiative as part of a broader strategy to create an inhospitable environment for federal workers.</p>
<p>The Office of Personnel Management, now facing legal challenges, will need to justify the plan's structure and funding sources as scrutiny intensifies.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/news/25/02/43527354/elon-musks-expanding-government-role-far-beyond-appropriate-gop-senator-warns"><strong>Elon Musk&#8217;s Expanding Government Role &#8216;Far Beyond&#8217; Appropriate, GOP Senator Warns</strong></a></li>
</ul>
<p><em>Photo: Chip Somodevilla/Shutterstock.com</em></p>


Government

Politics

Legal

AMZN

Trump's Push To Reshape Federal Workforce With Buyouts Stalls In Court

<p>Tell me you hate making money without actually saying you hate making money.</p>
<p>That is an easy one. Just say things like, &#8216;Bank stocks are boring.&#8217; Perhaps one might quip, &#8216;Bank stocks are too hard to understand.&#8217; Or too risky. Or irrelevant in the age of technology. Or in cahoots with global central banks to join Pinky and the Brain in a quest for global domination.</p>
<p>I have been investing in small banks for decades. Once you learn the rules of successful banking stock investing, it can be a wildly profitable endeavor. Historically, it has been a low beta, high alpha strategy.</p>
<p>Now, banks are emerging from the darkness, and the opportunity is more significant than it has been in years. The Biden administration was not kind to the banking industry. The term started with Saule Omarova&#8217;s nomination to a key regulatory post. Ms. Omarova grew up under the Soviet system and was pretty sure they had some good ideas about how to run a banking system. It ended with Biden appointees trying to hold US banks to much higher capital restrictions than those faced by European and Asian banks, creating what would have been a significant disadvantage had it been implemented. In between, it killed or delayed almost every bank deal that crossed its desk.</p>
<p>With Donald Trump back in the White House, I see the banking industry gearing up for another era of deregulation, consolidation, and renewed investor enthusiasm. Bank stocks, battered over the last couple of years by high interest rates, margin compression, and regulatory burdens, could finally be setting up for a powerful rally. Smart investors know that when politicians tinker with the system, it creates opportunity, especially in the world of small and regional banks.</p>
<p>Under Trump 2.0, I expect a significant rollback of regulatory red tape. The last administration made moves to ease restrictions under Dodd-Frank, particularly for smaller banks, and there&#8217;s every reason to believe that will continue. Banks with less than $250 billion in assets could see relaxed capital and liquidity requirements, freeing them up to lend more aggressively and improve returns on equity.</p>
<p>This is where the opportunity lies. Community and regional banks, long bogged down by compliance costs and stress-testing requirements that never really made sense for them, could finally breathe again. That means higher net interest margins, improved loan growth, and a more attractive operating environment overall. The market hasn&#8217;t priced this in yet, but it will.</p>
<p>I have long been a fan of small banks for one reason: consolidation. With nearly 4,000 banks in the U.S., we&#8217;re still long overdue for a serious round of mergers and acquisitions. The Trump administration is expected to take a much friendlier stance toward bank deal-making, particularly among regionals and smaller institutions.</p>
<p>The math here is simple. Larger banks are looking for growth, and organic loan expansion is slow. The fastest way to boost earnings is to acquire a smaller competitor, slash costs, and gain market share. Bank buyers have been hesitant due to regulatory uncertainty, but the floodgates could open with Trump in office and an expected rollback of Biden-era policies. The best-positioned investors will already have their watchlists filled with undervalued, high-quality community banks trading below book value.</p>
<p>For years, I&#8217;ve pounded the table on bank stocks, mainly those trading at or below tangible book value with strong loan portfolios and healthy deposit bases. There is massive upside in regional banks that are well-run but overlooked by the market. History shows that when regulatory burdens ease, small banks thrive.</p>
<p>One of the most reliable signals for excess returns in banking stocks is insider buying activity. Bank executives understand their balance sheets and growth potential better than anyone, and when they start buying shares in their own institutions, investors should pay attention. Studies have shown that banks with significant insider buying tend to outperform the market, especially when valuations are low. When you combine a favorable policy environment with strong insider conviction, you get a potent formula for gains.</p>
<p>Insiders have been aggressively buying several banks in the last month as they expect much better conditions and results under the new administration.</p>
<p>NB Bancorp (Ticker: NBBK) is a small but promising thrift that recently completed its mutual-to-stock conversion, setting the stage for long-term value creation. The bank operates out of the Greater Boston area with a focus on traditional lending, and it&#8217;s growing steadily in all the right places. Fourth-quarter numbers showed solid momentum, with net income jumping to $15.6 million, or $0.40 per share, while deposits and loans continued their steady climb. The net interest margin ticked up to 3.52%, and asset quality remains strong, with non-performing loans down double digits. The real kicker here is the stock buyback. Management is putting its money where its mouth is, authorizing a repurchase of 5% of outstanding shares. This one is worth a closer look for patient investors who appreciate a good conversion story with a strong capital base.</p>
<p>The people running the show are also enthusiastic about the future; in addition to the buyback, several insiders, including the CEO and CFO, have been buying shares recently.</p>
<p>Mid Penn Bancorp (Ticker: MPB) is a solid community bank operating primarily in Pennsylvania, demonstrating a consistent track record of growth and shareholder value. As of January 31, 2025, the stock is trading at $30.56 per share. In the fourth quarter of 2024, the bank reported earnings of $0.72 per share, contributing to a full-year profit increase of 32.2% to $49.4 million. Loan growth remained robust, with a $67.1 million increase in the third quarter, reflecting a 6.2% annualized growth rate. The bank&#8217;s commitment to returning capital to shareholders is evident through its repurchase of 15,500 shares at an average price of $20.81 in 2024. Additionally, CEO Rory G. Ritrievi recently acquired 3,050 shares at $30.05 each, signaling confidence in the bank&#8217;s trajectory. For investors seeking a stable, growth-oriented community bank with a shareholder-friendly approach, Mid Penn Bancorp presents a compelling opportunity.</p>
<p>We are coming into a golden age of bank stock returns. Tracking insiders and buying into situations where insiders have used their personal cash to express their confidence in the future should be a highly rewarding strategy.</p>


Opinion

NBBK

C-Suite Buy of the Week: Bank on It with Big Bets from Top Insiders

$BTC

Fed's Waller Says Asked About a Possible Bitcoin Strategic Reserve, Fed Would Not Run Such A Thing

<p>Shelling out millions of dollars for a Super Bowl commercial can be a risky move. Just ask the 14 companies with dot com in their name how things turned out after being featured in <a href="https://www.benzinga.com/topic/super-bowl">Super Bowl ads </a>in 2000.</p>
<p><strong>What Happened</strong>: Super Bowl XXXIV, which featured the St. Louis Rams and Tennessee Titans, will be remembered for many reasons, including being known as the "Dot-Com Super Bowl" due to the large number of companies with dot com in their name shelling out millions on<a href="https://www.benzinga.com/general/sports/25/01/43324031/super-bowl-lix-commercials-hit-record-8-million-how-fox-corporation-can-win-from-nfl-championship"> Super Bowl ads.</a></p>
<p>Super Bowl commercials for the NFL championship game in 2000 had a cost of around $2.2 million for a 30-second spot. Compare that to the $7 million to $8 million per 30-second spot that <strong>Fox Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>)(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXA#NASDAQ">FOXA</a>) is getting for this year's big game.</p>
<p>Here is the list of the dot-com companies that ran ads in Super Bowl XXXIV:</p>
<ul>
<li><strong>AutoTrader.com</strong>: Still Active</li>
<li><strong>Computer.com</strong>: Bought out by <strong>Office Depot </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODP#NASDAQ">ODP</a>) in 2000</li>
<li><strong>E1040.com</strong>: Defunct</li>
<li><strong>Epidemic.com</strong>: Defunct</li>
<li><strong>E-Stamp.com</strong>: Defunct</li>
<li><strong>HotJobs.com</strong>: Bought by Yahoo! in 2022 and later by Monster.com in 2010</li>
<li><strong>LastMinuteTravel.com</strong>: Active, merged with <strong>Tourico Holidays </strong>in 2004, acquired by <strong>Hotelbeds Group</strong> in 2017</li>
<li><strong>LifeMinders.com:</strong> Bought by <strong>Cross Media Group</strong> in 2001</li>
<li><strong>Monster.com</strong>: Active, bought by <strong>Randstad NV</strong> in 2016, now majority owned by <strong>Apollo Global</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>)</li>
<li><strong>OnMoney.com:</strong> Defunct</li>
<li><strong>Netpliance</strong>: Rebranded as <strong>Tipping Point </strong>in 2002, bought by 3Com in 2005</li>
<li><strong>OurBeginning.com:</strong> Bought by undisclosed company in 2002</li>
<li><strong>Pets.com:</strong> Defunct, website now redirects to <strong>PetSmart's </strong>website</li>
<li><strong>WebMD</strong>: Active, bought by<strong> Internet Brands</strong> in 2017</li>
</ul>
<p>Along with the 14 dot-com companies that ran ads, there were also several technology companies that were founded before the dot-com boom that aired ads in this Super Bowl. Those companies are:</p>
<ul>
<li><strong>Britannica</strong>: Active</li>
<li><strong>E&#x2A;Trade:</strong> Active, bought by <strong>Morgan Stanley</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) in 2020</li>
<li><strong>Electronic Data Systems:</strong> Bought by <strong>HP </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) in 2008</li>
<li><strong>Kforce</strong>: Active</li>
<li><strong>MicroStrategy</strong>: Active, changing name to Strategy and trades as <strong>MicroStrategy Inc </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>)</li>
</ul>
<p>As <a href="https://x.com/darrenrovell/status/1885071827145253163">pointed </a>out by <strong>cllct </strong>co-founder<strong> Darren Rovell</strong>, only three of the 14 dot-com companies that advertised in Super Bowl XXXIV still exist under the same name today (Autotrader, Monster, WebMD).</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/general/sports/24/02/37076429/super-bowl-commercials-2024-complete-list-of-super-bowl-lviii-ads-and-companies-behind-them">Super Bowl Commercials 2024: Complete List Of Super Bowl LVIII Ads And Companies Behind Them</a></strong></p>
<p><strong>Why It's Important: </strong>Super Bowl XXXIV was watched by more than 80 million people and many of the dot-com companies that advertised saw big spikes in website traffic.</p>
<p>LastMinuteTravel <a href="https://www.sfgate.com/business/networth/article/dot-com-super-bowl-advertisers-fumble-but-down-2739134.php">saw </a>over 300,000 hits per minute during its Super Bowl ads. OurBeginning.com's revenue was up 350% year-over-year in the first quarter of 2000. For most, the gains in traffic and revenue weren't enough to offset the high marketing costs on the Super Bowl ads.</p>
<p>Super Bowl XXXIV may have been one of the peak moments of the dot-com bubble with Barron's <a href="https://www.benzinga.com/general/education/19/03/11389594/this-day-in-market-history-barrons-calls-1bubble-top">calling the top</a> on March 20, 2000 with a cover story "Burning Up."</p>
<p>The 2001 Super Bowl (XXXV) featured only three dot-com companies as many of the prior year's companies had already gone under or were facing financial struggles. E&#x2A;Trade poked fun at the number of dot-com companies from the prior year during their Super Bowl XXXV ad.</p>
<p>The Dot-Com Super Bowl of 2000 hit the spotlight again in 2022 when a large number of cryptocurrency companies ran Super Bowl ads in Super Bowl LVI,<a href="https://www.benzinga.com/markets/cryptocurrency/22/02/25569962/super-bowl-lvi-becomes-crypto-bowl-with-commercials-ad-campaigns-for-big-game"> prompting the nickname</a> of the "Crypto Bowl."</p>
<p>Among the companies that advertised during Super Bowl LVI was <strong>FTX</strong>, a cryptocurrency platform that went bankrupt less than a year after its Super Bowl commercial.</p>
<p>Spending millions of dollars on a Super Bowl commercial is not a proven path to success, especially for smaller unproven and unprofitable companies. Food for thought as you watch this year's Super Bowl ads.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/general/sports/25/02/43480342/chiefs-chase-historic-super-bowl-three-peat-and-nba-legend-stands-to-gain">Chiefs Chase Historic Super Bowl Three-Peat — And NBA Legend Stands To Gain</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Entertainment

Sports

FOXA

MSTR

14 Dot-Com Companies Had Super Bowl Commercials In 2000, Here's How Many Still Exist Today

$USDC

Fed's Waller Says A Stablecoin Is Like A Synthetic Dollar, If It Makes Payments Faster, Cheaper, I'm All For It; Need Regulation for Stablecoins, the Faster the Better; Stablecoins Will Make Dollar Even More Of A Reserve Currency Than It Is Now

Moleculin Biotech ( ($MBRX) ) just unveiled an announcement. Moleculin Biotech has revealed promising findings showcasing Annamycin's potential to ...

Moleculin Biotech Advances Annamycin for AML Treatment

Moleculin Biotech ( ($MBRX) ) has issued an update. Moleculin Biotech, Inc. announced the use of a new corporate presentation on November 18, 2024,...

Moleculin Biotech Unveils New Corporate Presentation

Moleculin Biotech ( ($MBRX) ) has provided an update. Moleculin Biotech announced the online publication of preclinical data showing significant ac...

Moleculin Biotech files for stock and warrants offering

17:04 EST Moleculin Biotech (MBRX) files to sell common stock, warrants, no amount given Published first on TheFly – the ultimate source for real-t...

Moleculin Biotech files to sell common stock, warrants, no amount given

Moleculin Biotech ( ($MBRX) ) has issued an update. Moleculin Biotech, Inc. announced the use of a corporate presentation as part of its communicat...

Moleculin Biotech Shares Corporate Presentation Update

Moleculin Biotech ( ($MBRX) ) has provided an update. Moleculin Biotech announced significant progress in the development of its drug Annamycin, pa...

Moleculin Biotech Advances Annamycin to Phase 3 Trial

In a report released on January 10, Jonathan Aschoff from Roth MKM assigned a Buy rating to Moleculin Biotech (MBRX – Research Report), with a pric...

Moleculin Biotech (MBRX) Gets a Buy from Roth MKM

The latest update is out from Moleculin Biotech ( ($MBRX) ). On January 27, 2025, Moleculin Biotech announced that its CEO, Walter Klemp, participa...

Moleculin Biotech Shares Updates on MIRACLE Trial

The latest update is out from Moleculin Biotech ( ($MBRX) ). On January 27, 2025, Moleculin Biotech announced the launch of its MIRACLE pivotal stu...

Moleculin Biotech Launches MIRACLE Study for AML

Small Cap

Press Releases

Transcript from Moleculin's Recent Virtual Acute Myeloid Leukemia KOL Event Now Available

Moleculin Appoints Leading Expert in Pancreatic Cancer to its Scientific Advisory Board to Support Development of Annamycin

Moleculin to Report Third Quarter 2024 Financial Results on November 8, 2024 and Host Conference Call and Webcast

Earnings

Moleculin Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Moleculin Receives Institutional Review Board Approval for MIRACLE Phase 3 Pivotal Trial of Annamycin in Combination with Cytarabine for the Treatment of R/R Acute Myeloid Leukemia (AML)

Comments

Moleculin Biotech

Moleculin Biotech (MBRX) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL